| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
DHODH-IN-13 manufacturers
- DHODH-IN-13
-
- $125.00
-
2026-07-14
- CAS:1364791-86-5
- Purity: 99.66%
- Supply Ability: 10g
- DHODH-IN-13
-
- $125.00
-
2026-07-14
- CAS:1364791-86-5
- Purity: 99.66%
- Supply Ability: 10g
|
| | DHODH-IN-13 Basic information |
| Product Name: | DHODH-IN-13 | | Synonyms: | DHODH-IN-13;DHODH IN 13,DHODHIN13;1,2,5-Oxadiazole-3-carboxamide, 4,5-dihydro-4-oxo-N-[4-(trifluoromethyl)phenyl]-;DHODH-IN-13, 10 mM in DMSO | | CAS: | 1364791-86-5 | | MF: | C10H6F3N3O3 | | MW: | 273.17 | | EINECS: | | | Product Categories: | | | Mol File: | 1364791-86-5.mol |  |
| | DHODH-IN-13 Chemical Properties |
| density | 1+-.0.1 g/cm3(Predicted) | | pka | 9.75±0.70(Predicted) |
| | DHODH-IN-13 Usage And Synthesis |
| Uses | DHODH-IN-13 (Compound 7a) is a hydroxyfurazan analog of A771726. DHODH-IN-13 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 4.3 μM for rat liver DHODH. DHODH-IN-13 can be used for rheumatoid arthritis[1]. | | References | [1] Lolli ML, et al. New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold. Eur J Med Chem. 2012 Mar;49:102-9. DOI:10.1016/j.ejmech.2011.12.038 |
| | DHODH-IN-13 Preparation Products And Raw materials |
|